{"id":"https://openalex.org/W2319207837","doi":"https://doi.org/10.1097/00008877-200305000-00007","title":"Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine","display_name":"Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W2319207837","doi":"https://doi.org/10.1097/00008877-200305000-00007","mag":"2319207837","pmid":"https://pubmed.ncbi.nlm.nih.gov/12799525"},"language":"en","primary_location":{"id":"doi:10.1097/00008877-200305000-00007","doi":"https://doi.org/10.1097/00008877-200305000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-200305000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2319207837"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066903149","display_name":"Jean De Vry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. De Vry","raw_affiliation_strings":["CNS Research, Bayer Health Care, Aprather Weg 18a, 42096 Wuppertal, Germany. jean.vry.jv1@bayer-ag.de","CNS Research, Bayer Health Care, Aprather Weg 18a, 42096 Wuppertal, Germany","E-mail: [email\u00a0protected]","Received 15 December 2002 Accepted as revised 5 February 2003"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Research, Bayer Health Care, Aprather Weg 18a, 42096 Wuppertal, Germany. jean.vry.jv1@bayer-ag.de","institution_ids":[]},{"raw_affiliation_string":"CNS Research, Bayer Health Care, Aprather Weg 18a, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"Received 15 December 2002 Accepted as revised 5 February 2003","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055734482","display_name":"Klaus R\u00fcdiger Jentzsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K.R. Jentzsch","raw_affiliation_strings":["CNS Research, Bayer Health Care, Aprather Weg 18a, 42096 Wuppertal, Germany","E-mail: [email\u00a0protected]","Received 15 December 2002 Accepted as revised 5 February 2003"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Research, Bayer Health Care, Aprather Weg 18a, 42096 Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"Received 15 December 2002 Accepted as revised 5 February 2003","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5066903149"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":null,"apc_paid":null,"fwci":1.0399,"has_fulltext":false,"cited_by_count":49,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.69208081,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"14","issue":"3","first_page":"229","last_page":"235"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.5835000276565552,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.5835000276565552,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.23549999296665192,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0658000037074089,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.8759999871253967},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8539999723434448},{"id":"https://openalex.org/keywords/nr2b-subunit","display_name":"NR2B subunit","score":0.9990000128746033},{"id":"https://openalex.org/keywords/discriminative-stimulus-effects","display_name":"discriminative stimulus effects","score":0.75},{"id":"https://openalex.org/keywords/psychotomimetic-side-effects","display_name":"psychotomimetic side effects","score":0.8169999718666077},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.8429999947547913},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ifenprodil","display_name":"ifenprodil","score":0.9409999847412109},{"id":"https://openalex.org/keywords/ro-25-6981","display_name":"Ro 25-6981","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.7799999713897705},{"id":"https://openalex.org/keywords/generalization","display_name":"generalization","score":0.7049999833106995},{"id":"https://openalex.org/keywords/dissociative-anesthetics","display_name":"dissociative anesthetics","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2781065190","wikidata":"https://www.wikidata.org/wiki/Q7256512","display_name":"Psychotomimetic","level":4,"score":0.9483657479286194},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.878187894821167},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.8735830783843994},{"id":"https://openalex.org/C2777836312","wikidata":"https://www.wikidata.org/wiki/Q4386371","display_name":"Dizocilpine","level":4,"score":0.8184641599655151},{"id":"https://openalex.org/C2780376555","wikidata":"https://www.wikidata.org/wiki/Q5991156","display_name":"Ifenprodil","level":4,"score":0.8149734735488892},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6665010452270508},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.5818477869033813},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45337623357772827},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.43854591250419617},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28716325759887695},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.25759655237197876},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.24856001138687134},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20690608024597168},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1058686375617981}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004192","descriptor_name":"Discrimination, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004193","descriptor_name":"Discrimination Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010636","descriptor_name":"Phenols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012054","descriptor_name":"Reinforcement, Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008877-200305000-00007","doi":"https://doi.org/10.1097/00008877-200305000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-200305000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},{"id":"pmid:12799525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12799525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.46810001134872437}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1819848802","https://openalex.org/W1842976670","https://openalex.org/W1898334791","https://openalex.org/W1906355880","https://openalex.org/W1965870634","https://openalex.org/W1967547000","https://openalex.org/W1975275982","https://openalex.org/W1981845512","https://openalex.org/W1988043537","https://openalex.org/W1998482987","https://openalex.org/W2000808619","https://openalex.org/W2001311215","https://openalex.org/W2001721703","https://openalex.org/W2007435580","https://openalex.org/W2026776441","https://openalex.org/W2028884770","https://openalex.org/W2045232188","https://openalex.org/W2066869040","https://openalex.org/W2072040762","https://openalex.org/W2080519186","https://openalex.org/W2083161480","https://openalex.org/W2094126290","https://openalex.org/W2107212183","https://openalex.org/W2127684120","https://openalex.org/W2138643360","https://openalex.org/W2143653836","https://openalex.org/W2151893882"],"related_works":["https://openalex.org/W2026776441","https://openalex.org/W2033011495","https://openalex.org/W2049050212","https://openalex.org/W2041234637","https://openalex.org/W2007023757","https://openalex.org/W3110685581","https://openalex.org/W2091812013","https://openalex.org/W587942524","https://openalex.org/W282925303"],"abstract_inverted_index":{"The":[0],"noncompetitive":[1,27,166],"N-methyl-D-aspartate":[2],"(NMDA)":[3],"receptor":[4],"antagonist,":[5],"ketamine,":[6,92,135],"is":[7,18,47,53,158],"a":[8,74,81,128],"dissociative":[9],"anesthetic":[10],"with":[11,112],"antihyperalgesic":[12],"properties.":[13],"However,":[14],"its":[15],"clinical":[16],"use":[17],"compromised":[19],"by":[20],"psychotomimetic":[21,57,177],"side-effects.":[22,58,79,178],"As":[23],"ketamine":[24,70,124],"and":[25,33,89,95,100,138,169],"other":[26],"NMDA":[28,44,167],"antagonists,":[29,168],"such":[30,78],"as":[31],"phencyclidine":[32,94,137],"dizocilpine,":[34,93,136],"are":[35],"not":[36],"selective":[37,171],"for":[38,55,77],"the":[39,43,56,62,65,69,96,155,161],"NR2A-2D":[40],"subunits":[41,52],"of":[42,50,64,165],"receptor,":[45],"it":[46],"unclear":[48],"which":[49],"these":[51],"responsible":[54],"This":[59],"study":[60],"investigated":[61],"role":[63],"NR2B":[66,156,172],"subunit":[67,157],"in":[68,110,127,160],"drug":[71],"discrimination":[72],"model,":[73],"possible":[75],"correlate":[76],"In":[80,119],"first":[82],"experiment":[83],"aimed":[84],"at":[85],"assessing":[86],"general":[87],"potency":[88],"time":[90],"dependency,":[91],"NR2B-selective":[97],"antagonists":[98,173],"ifenprodil":[99,146],"Ro":[101,139],"25-6981,":[102],"dose-dependently":[103],"suppressed":[104],"fixed":[105,130],"ratio":[106,131],"10":[107,132],"food-reinforced":[108,133],"responding":[109],"rats,":[111],"peak":[113],"efficacy":[114],"obtained":[115],"around":[116],"15-40":[117],"min.":[118],"rats":[120],"trained":[121],"to":[122],"discriminate":[123],"from":[125],"vehicle":[126],"two-lever":[129],"procedure,":[134],"25-6981":[140],"induced":[141,147],"complete":[142],"generalization":[143,149],"(>80%);":[144],"whereas":[145],"partial":[148],"(33%).":[150],"These":[151],"findings":[152],"suggest":[153],"that":[154,170],"involved":[159],"discriminative":[162],"stimulus":[163],"effects":[164],"may":[174],"also":[175],"induce":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2319207837","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
